Lolu lwazi lungenzelwe izinjongo zemfundo kuphela. Aluhloselwe ukuba yiseluleko sezokwelapha. Hlala ubonisana nochwepheshe wezempilo ofanelekile.
Incazelo, Umthamo, Imiphumela Engemihle, Izithiyo. Data from EMA, URPL, openFDA and other regulatory sources.
| Amlodipine | Lisinopril | |
|---|---|---|
| Izithako Ezisebenzayo | AMLODIPINE (AMLODIPINE BESYLATE) | LISINOPRIL |
| Ikhodi ye-ATC | C08CA01 | C09AA03 |
| Isimo | — | TABLET |
| Umthamo | — | 10 mg/1 |
| Indlela Yokuthatha | — | ORAL |
| Umkhiqizi | JUBILANT GENERICS LIMITED | Preferred Pharmaceuticals Inc. |
Amlodipine (INN: AMLODIPINE (AMLODIPINE BESYLATE), ATC C08CA01) and Lisinopril (INN: LISINOPRIL, ATC C09AA03) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
Lolu lwazi lungenzelwe izinjongo zemfundo kuphela. Aluhloselwe ukuba yiseluleko sezokwelapha. Hlala ubonisana nochwepheshe wezempilo ofanelekile.